3-(2-(3-(4-ethoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)hydrazinecarbothioamido)benzoic acid

ID: ALA4286087

Chembl Id: CHEMBL4286087

PubChem CID: 145992870

Max Phase: Preclinical

Molecular Formula: C24H21N5O4S

Molecular Weight: 475.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1ccc(-n2c(NNC(=S)Nc3cccc(C(=O)O)c3)nc3ccccc3c2=O)cc1

Standard InChI:  InChI=1S/C24H21N5O4S/c1-2-33-18-12-10-17(11-13-18)29-21(30)19-8-3-4-9-20(19)26-23(29)27-28-24(34)25-16-7-5-6-15(14-16)22(31)32/h3-14H,2H2,1H3,(H,26,27)(H,31,32)(H2,25,28,34)

Standard InChI Key:  AZHBECHWJLAZSQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4286087

    ---

Associated Targets(Human)

MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cckbr Cholecystokinin B receptor (729 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckbr Cholecystokinin B receptor (792 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 475.53Molecular Weight (Monoisotopic): 475.1314AlogP: 3.80#Rotatable Bonds: 7
Polar Surface Area: 117.51Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.94CX Basic pKa: 2.39CX LogP: 4.37CX LogD: 1.31
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -1.58

References

1. Kumari S, Chowdhury J, Sikka M, Verma P, Jha P, Mishra AK, Saluja D, Chopra M..  (2017)  Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells.,  (7): [PMID:30108868] [10.1039/C7MD00171A]

Source